| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033108 |
| Receipt No. | R000037752 |
| Official scientific title of the study | Pharmacokinetics study of food ingredient. SWE-2018-03-HR1002 |
| Date of disclosure of the study information | 2018/06/25 |
| Last modified on | 2018/12/26 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Pharmacokinetics study of food ingredient.
SWE-2018-03-HR1002 |
|
| Title of the study (Brief title) | Pharmacokinetics study of food ingredient. | |
| Region |
|
|
| Condition | ||
| Condition | Not applicable | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the pharmacokinetics of food ingredient. |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Maximum observed plasma concentration, Area under the plasma concentration-time curve from time zero to the time of the last measurable drug concentration. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Single ingestion of test food 1->Washout (12days or more)->Single ingestion of test food 2. | |
| Interventions/Control_2 | Single ingestion of test food 2->Washout (12days or more)->Single ingestion of test food 1. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Male and Female whose age are 20 <= years old <65.
(2)Subjects who are able to submit the written informed consents. |
|||
| Key exclusion criteria | (1)Subjects who are with treatment.
(2)Subjects who are with history of gastrointestinal surgery. (3)Subjects who are attending other studies or attended other studies within the past 4 weeks. (4)Subjects who are; a)With present heart disorder, liver disorder, or kidney disorder, b)With history of cardiac disorder, c)With diabetes mellitus, or d)With allergy to the study foods. (5)Subjects who are not negative for syphilis, HBs antigen, HCV antibody, HIV antigen/antibody or HTLV-1 antibody test. (6)Subjects who are deemed to be unsuitable by the investigator. |
|||
| Target sample size | 16 | |||
| Research contact person | |
| Name of lead principal investigator | Takao Tanaka |
| Organization | SUNTORY WELLNESS LIMITED |
| Division name | Institute for Health Care Science |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan |
| TEL | 050-3182-0590 |
| Takao_Tanaka@suntory.co.jp | |
| Public contact | |
| Name of contact person | Namino Tomimori |
| Organization | SUNTORY WELLNESS LIMITED |
| Division name | Institute for Health Care Science |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan |
| TEL | 050-3182-0651 |
| Homepage URL | |
| Namino_Sugiura@suntory.co.jp | |
| Sponsor | |
| Institute | SUNTORY WELLNESS LIMITED |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SUNTORY WELLNESS LIMITED |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037752 |